Texas Instruments jumps 3.7% as chip-cycle recovery optimism and fresh analyst target hikes lift sentiment - Quiver Quantitative
π TXN shares jumped 3.7% on March 24, 2026, fueled by chip-cycle recovery optimism and fresh analyst upgrades.
π° The company guided for Q1 revenue of $4.32B-$4.68B and EPS of $1.22-$1.48, signaling stabilizing demand.
π Analysts cite moderating capital intensity and expanding free-cash-flow potential as key drivers for the stock.
π₯οΈ Data-center demand is identified as a specific incremental support for the analog portfolio.
π― Cantor Fitzgerald analyst Matthew Prisco set a price target of $250.0 on February 23, 2026.
π¦ UBS analyst Timothy Arcuri raised the target to $260.0 on January 28, 2026.
π Insider selling continues with CFO Rafael R Lizardi offloading 71,628 shares in the last six months.
ποΈ Institutional activity shows mixed signals with D.E. Shaw adding 3.6M shares while UBS reduced holdings by 77%.
- Texas Instruments is benefiting from a perceived recovery in the analog semiconductor cycle, leading to a 3.7% stock price increase.
- The company's March quarter guidance of $4.32B-$4.68B revenue suggests that sequential growth is returning and demand is stabilizing.
- Analysts emphasize that capital intensity is moderating after years of capacity build, which should expand free-cash-flow potential.
- Specific strength in data-center-related demand is providing incremental support to the company's broader analog portfolio.
- Multiple major firms including Cantor Fitzgerald and UBS have issued price targets above $240, indicating strong bullish sentiment.
- Insider trading data shows a net selling trend over the past six months, with zero purchases recorded against 12 sales by senior executives.
- Major institutional investors like UBS Asset Management and Bank of America significantly reduced their positions in Q4 2025, removing billions in value.
- Analyst consensus includes mixed ratings, with Mizuho issuing an 'Underperform' rating alongside multiple 'Buy' recommendations from other firms.